Defiance Daily Target 2X Long LLY ETF(LLYX.US)

Last Updated 19:00:00 ET
longbridge loading

Eli Lilly (LLY) Is the Face of the Obesity Boom. Has the Market Already Priced It In?

Tip Ranks·
US
LLY
+2.20%
US
LLYX
+4.56%
US
ELIS
0.00%
Tip Ranks·
US
LLY
+2.20%
US
LLYX
+4.56%
US
ELIS
0.00%

Eli Lilly’s New Alopecia Drug Trial Moves Forward, Expanding Its Immunology Pipeline

Tip Ranks·
US
LLY
+2.20%
US
FBT
-0.54%
US
LLYX
+4.56%
Tip Ranks·
US
LLY
+2.20%
US
FBT
-0.54%
US
LLYX
+4.56%

Lilly and UNICEF collaborate to give millions of children a healthier start

Unusual Whales·
US
LLY
+2.20%
US
LABU
-3.79%
US
LLYZ
0.00%
Unusual Whales·
US
LLY
+2.20%
US
LABU
-3.79%
US
LLYZ
0.00%

Lilly allies with Caitlin Clark for Indianapolis sports courts

Fiercepharma·
US
LLY
+2.20%
US
LLYX
+4.56%
US
ELIL
+3.93%
Fiercepharma·
US
LLY
+2.20%
US
LLYX
+4.56%
US
ELIL
+3.93%

1,397 Shares in Eli Lilly and Company $LLY Purchased by Stonebridge Financial Group LLC MO

Market Beat·
US
LLY
+2.20%
US
LLYX
+4.56%
US
ELIL
+3.93%
Market Beat·
US
LLY
+2.20%
US
LLYX
+4.56%
US
ELIL
+3.93%

Eli Lilly Says Newly Approved Foundayo, Lower-Dose Zepbound Help Sustain Weight Loss

benzinga_article·
US
LLY
+2.20%
US
XLV
+0.80%
US
VHT
+0.60%
benzinga_article·
US
LLY
+2.20%
US
XLV
+0.80%
US
VHT
+0.60%

07:27 ETWMHW Secures Victory; U.S. Supreme Court Denies Eli Lilly's Petition for Certiorari, Finalizing $220M+ False Claims Act Judgment

prnewswire·
US
LLY
+2.20%
US
IBBQ
-0.81%
US
IBB
-0.38%
prnewswire·
US
LLY
+2.20%
US
IBBQ
-0.81%
US
IBB
-0.38%

Lilly's Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials | LLY Stock News

StockTitan·
US
LLY
+2.20%
US
IHE
+0.37%
US
LLYX
+4.56%
StockTitan·
US
LLY
+2.20%
US
IHE
+0.37%
US
LLYX
+4.56%

Supreme Court Rejects Eli Lilly Appeal In Medicaid Fraud Case

Fidelity·
US
LLY
+2.20%
US
LABU
-3.79%
US
VHT
+0.60%
Fidelity·
US
LLY
+2.20%
US
LABU
-3.79%
US
VHT
+0.60%
© 2026 Longbridge｜Disclaimer